Serum Cytokine Levels in Patients With Hepatoblastoma
| Case No. . | Platelet Count at Diagnosis (/μL) . | TPO* (fmol/mL) . | IL-1β* (pg/mL) . | IL-6* (pg/mL) . |
|---|---|---|---|---|
| Case 1 | 986,000 | 6.82 | 0.56 | 41 |
| Case 2 | 529,000 | 3.31 | ND | ND |
| Case 3 | 715,000 | 11.02 | ND | ND |
| Case 4 | 603,000 | 3.15 | <0.125 | 6.55 |
| Case 5 | 718,000 | 4.2 | 0.16 | 1.62 |
| Case 6 | 704,000 | 3.96 | 0.338 | 31.3 |
| Case 7 | 1,150,000 | 10.1 | 0.153 | 33.8 |
| Case No. . | Platelet Count at Diagnosis (/μL) . | TPO* (fmol/mL) . | IL-1β* (pg/mL) . | IL-6* (pg/mL) . |
|---|---|---|---|---|
| Case 1 | 986,000 | 6.82 | 0.56 | 41 |
| Case 2 | 529,000 | 3.31 | ND | ND |
| Case 3 | 715,000 | 11.02 | ND | ND |
| Case 4 | 603,000 | 3.15 | <0.125 | 6.55 |
| Case 5 | 718,000 | 4.2 | 0.16 | 1.62 |
| Case 6 | 704,000 | 3.96 | 0.338 | 31.3 |
| Case 7 | 1,150,000 | 10.1 | 0.153 | 33.8 |
Abbreviation: ND, not done.
Normal range in adults as follows: TPO 0.33 to 1.72 fmol/mL, IL-1β <0.567 pg/mL, IL-6 0.157 to 2.94 pg/mL.